Aligos therapeutics to present at the jefferies global healthcare conference

South san francisco, calif., may 29, 2025 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will present at the jefferies global healthcare conference on thursday, june 5, 2025 at 2:00pm et.
ALGS Ratings Summary
ALGS Quant Ranking